Patrick Schnegelsberg
Chief Executive Officer at SynCardia Systems LLC
Profile
Patrick N.
J.
Schnegelsberg is currently the Chief Executive Officer at SynCardia Systems LLC and Picard Medical Holdings, Inc. He is also the Director at Acorai AB since 2022.
In the past, he worked as the Chief Executive Officer at Gammacan International, Inc. from 2006 to 2008, and as the Chief Operating Officer at Occlutech Holding AG from 2012 to 2021.
He was also the Co-Chief Executive Officer at Syntach AB in 2023 and an Independent Director at Scandinavian Real Heart AB from 2022 to 2023.
Mr. Schnegelsberg received his undergraduate degree from Massachusetts Institute of Technology and Harvard Medical School, and his graduate degree from Harvard University.
He also received an undergraduate degree from Clark University in 1989.
Patrick Schnegelsberg active positions
| Companies | Position | Start |
|---|---|---|
SynCardia Systems LLC
 SynCardia Systems LLC Medical SpecialtiesHealth Technology SynCardia Systems LLC engages in the manufacture of temporary total artificial heart. Its total artificial heart provides immediate, safe blood flow of up to 9.5 L/min through each ventricle. The company was founded by Marvin J. Slepian, Jack G. Copeland, and Richard G. Smith in 2001 and is headquartered in Tucson, AZ. | Chief Executive Officer | - |
Acorai AB
 Acorai AB Medical SpecialtiesHealth Technology Acorai AB is a Swedish medical device company founded in 2019. The company is based in Stockholm, Sweden. The company is developing a scalable medical device for non-invasive intracardiac pressure monitoring to improve heart failure management for more than 64 million patients worldwide. | Director/Board Member | 2022-03-31 |
Former positions of Patrick Schnegelsberg
| Companies | Position | End |
|---|---|---|
Syntach AB
 Syntach AB Medical SpecialtiesHealth Technology Syntach AB is a Swedish company based in Lund that specializes in developing a revolutionary, minimally invasive long-term cardiac support device and mitral valve repair technology for people suffering from severe heart failure. Syntach has close links and extensive cooperation with various institutions at the University of Lund. The company is also developing a minimally-invasive device to correct mitral valve regurgitation, which can be used in combination with the cardiac support device or on a standalone basis. The company was founded in 2012 with the aim of creating an entirely new class of cardiac support devices to improve the care of the rapidly-growing number of people with heart failure. The company was founded by Tor Peters and Jan Otto Solem, who have been the CEOs since incorporation. | Chief Executive Officer | 2023-06-30 |
Scandinavian Real Heart AB
 Scandinavian Real Heart AB Medical SpecialtiesHealth Technology Scandinavian Real Heart AB engages in the development of mechanical cardiac pumps. It offers an artificial heart that recreates the flow, pressure, and control of a pumping heart and can be used for patients awaiting heart transplants. The company was founded by Azad Najar, Gunnar Nihlén, and Said Zahrai in 1999 and is headquartered in Västerås, Sweden. | Director/Board Member | 2023-06-06 |
| OCCLUTECH HOLDING AG | Chief Executive Officer | - |
Gammacan International, Inc.
 Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Chief Executive Officer | 2008-10-31 |
Training of Patrick Schnegelsberg
| Clark University | Undergraduate Degree |
| Harvard University | Graduate Degree |
| Harvard Medical School | Undergraduate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
 | Health Technology |
| Private companies | 5 |
|---|---|
Gammacan International, Inc.
Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Health Technology |
Syntach AB
Syntach AB Medical SpecialtiesHealth Technology Syntach AB is a Swedish company based in Lund that specializes in developing a revolutionary, minimally invasive long-term cardiac support device and mitral valve repair technology for people suffering from severe heart failure. Syntach has close links and extensive cooperation with various institutions at the University of Lund. The company is also developing a minimally-invasive device to correct mitral valve regurgitation, which can be used in combination with the cardiac support device or on a standalone basis. The company was founded in 2012 with the aim of creating an entirely new class of cardiac support devices to improve the care of the rapidly-growing number of people with heart failure. The company was founded by Tor Peters and Jan Otto Solem, who have been the CEOs since incorporation. | Health Technology |
SynCardia Systems LLC
SynCardia Systems LLC Medical SpecialtiesHealth Technology SynCardia Systems LLC engages in the manufacture of temporary total artificial heart. Its total artificial heart provides immediate, safe blood flow of up to 9.5 L/min through each ventricle. The company was founded by Marvin J. Slepian, Jack G. Copeland, and Richard G. Smith in 2001 and is headquartered in Tucson, AZ. | Health Technology |
Acorai AB
Acorai AB Medical SpecialtiesHealth Technology Acorai AB is a Swedish medical device company founded in 2019. The company is based in Stockholm, Sweden. The company is developing a scalable medical device for non-invasive intracardiac pressure monitoring to improve heart failure management for more than 64 million patients worldwide. | Health Technology |
Occlutech Holding AG
 Occlutech Holding AG Medical SpecialtiesHealth Technology Occlutech Holding AG manufactures cardiac implant products. The firm?s products include Occlutech PLD, Occlutech Figulla Flex II, Sizing Occlutech ASD, Occlutech PDA Occluder, Occlutech Delivery Set and Occlutech Stiff Guide Wire. The company is headquartered in Schaffhausen, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Patrick Schnegelsberg
